• 1. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
• 2. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 3. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 4. Distinctive size effects of Pt nanoparticles immobilized on Fe3O4@PPy used as an efficient recyclable catalyst for benzylic alcohol aerobic oxidation and hydrogenation reduction of nitroaromatics
  Yu Long,Bing Yuan,Jianrui Niu,Xin Tong,Jiantai Ma New J. Chem., 2015,39, 1179-1185
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives

Introduction to 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide (CAS No. 89270-68-8) and Its Emerging Applications in Chemical Biology

The compound 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide (CAS No. 89270-68-8) represents a fascinating intersection of medicinal chemistry and bioorganic synthesis. Its unique structural framework, featuring a benzohydrazide moiety linked to a pyrazole derivative, has garnered significant attention in recent years due to its potential pharmacological properties. This introduction delves into the compound's chemical characteristics, synthetic pathways, and its emerging role in cutting-edge research.

From a structural perspective, the presence of 3,4,5-trimethoxybenzohydrazide as the core scaffold provides a rich platform for further functionalization. The methoxy groups introduce lipophilicity and electronic modulation, while the benzohydrazide moiety is well-documented for its reactivity in forming Schiff bases and heterocyclic compounds. The appended 3-methyl-1H-pyrazole-5-carbonyl group not only enhances the molecular complexity but also opens avenues for interactions with biological targets such as enzymes and receptors.

In the realm of synthetic methodologies, the preparation of 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide involves multi-step organic transformations that highlight the compound's synthetic versatility. Key steps typically include condensation reactions between appropriately substituted benzhydrazides and pyrazole derivatives under controlled conditions. Advances in catalytic systems have enabled more efficient and scalable syntheses, making this compound more accessible for medicinal chemists. Recent studies have demonstrated that microwave-assisted synthesis can significantly reduce reaction times while maintaining high yields, underscoring the importance of modern synthetic techniques.

The pharmacological relevance of 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide has been explored in several preclinical studies. Its benzohydrazide component is known to exhibit inhibitory activity against various enzymes implicated in metabolic disorders and inflammatory pathways. Notably, preliminary data suggest that derivatives of this compound may interfere with the activity of polyphenol oxidases (PPOs), which are enzymes involved in plant defense mechanisms but also relevant to human health conditions such as oxidative stress-related diseases.

Emerging research has also highlighted the potential of this scaffold in modulating immune responses. The pyrazole moiety is frequently associated with immunomodulatory activities, and recent studies have shown that certain pyrazole-based compounds can influence cytokine production and T-cell differentiation. The methoxy-substituted benzene ring further contributes to these effects by enhancing binding affinity to biological targets. These findings position 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide as a promising candidate for developing novel immunotherapeutic agents.

Furthermore, the compound's ability to form coordination complexes with metal ions has opened new avenues in metallodrug development. Metallopharmaceuticals are gaining traction as alternative therapeutic strategies due to their unique binding properties and bioavailability profiles. Studies indicate that complexes formed between 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide and transition metals such as copper or zinc exhibit enhanced stability and improved cellular uptake. These complexes show promise in targeting cancer cells by inducing oxidative stress and disrupting mitochondrial function.

The role of computational chemistry in optimizing derivatives of 3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide cannot be overstated. Molecular modeling techniques have enabled researchers to predict binding affinities and identify key interaction sites with biological targets at an atomic level. This approach has accelerated the discovery process by allowing rapid screening of virtual libraries before experimental validation. Such computational strategies are particularly valuable in drug design pipelines where high-throughput screening would be computationally expensive or time-consuming.

In conclusion,3,4,5-trimethoxy-N'-(3-methyl-1H-pyrazole-5-carbonyl)benzohydrazide (CAS No. 89270-68-8) stands as a versatile scaffold with significant potential across multiple domains of chemical biology and drug discovery. Its unique structural features enable diverse applications ranging from enzyme inhibition to immunomodulation and metallodrug development. As research continues to uncover new therapeutic possibilities,this compound is poised to play an increasingly important role in addressing complex biological challenges.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)